Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
15.41
0.00 (0.00%)
At close: Jan 8, 2026, 4:00 PM EST
15.41
0.00 (0.00%)
After-hours: Jan 8, 2026, 7:01 PM EST
Dynavax Technologies Employees
Dynavax Technologies had 405 employees as of December 31, 2024. The number of employees decreased by 3 or -0.74% compared to the previous year.
Employees
405
Change (1Y)
-3
Growth (1Y)
-0.74%
Revenue / Employee
$816,084
Profits / Employee
-$107,163
Market Cap
1.75B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 405 | -3 | -0.74% |
| Dec 31, 2023 | 408 | 57 | 16.24% |
| Dec 31, 2022 | 351 | 40 | 12.86% |
| Dec 31, 2021 | 311 | 66 | 26.94% |
| Dec 31, 2020 | 245 | 14 | 6.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
DVAX News
- 15 days ago - Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying - Investopedia
- 15 days ago - This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. - Barrons
- 15 days ago - Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37% - Invezz
- 15 days ago - Sanofi to acquire US biotech Dynavax for $2.2 billion - Reuters
- 15 days ago - Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal - WSJ
- 15 days ago - Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline - PRNewsWire
- 15 days ago - Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline - GlobeNewsWire
- 7 weeks ago - Dynavax to Participate at the 8th Annual Evercore Healthcare Conference - PRNewsWire